No connection

Search Results

CNS

BEARISH
$67.71 Live
Cohen & Steers, Inc. · NYSE
Target $66.33 (-2.0%)
$58.39 52W Range $83.99

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 25, 2026
Market cap
$3.48B
P/E
22.42
ROE
N/A
Profit margin
27.5%
Debt/Equity
0.22
Dividend yield
3.96%

AI Analysis

AI-powered fundamental assessment

Confidence
85%
CNS exhibits a stable financial foundation with a Piotroski F-Score of 5/9 and very low debt (D/E 0.22), but it is fundamentally overvalued. The current price of $67.71 trades at a significant premium to both the Graham Number ($27.35) and the growth-based Intrinsic Value ($50.59). This valuation gap is compounded by a bearish technical trend (0/100), insider selling, and a dangerously high dividend payout ratio of 83.77%. Recent earnings performance is lackluster, with only one beat in the last four quarters.

Key Strengths

Strong operating margins (34.41%) and profit margins (27.46%)
Very low leverage with a Debt/Equity ratio of 0.22
Stable financial health as indicated by a Piotroski F-Score of 5/9
Consistent long-term price appreciation (5Y Change +17.7%)
Positive YoY revenue growth of 8.30%

Key Risks

Significant overvaluation relative to intrinsic value ($50.59) and Graham number ($27.35)
Unsustainable dividend payout ratio (83.77%) limiting capital reinvestment
Bearish technical momentum (0/100) and negative 1-year price performance (-8.7%)
Poor recent earnings track record (1/4 beats in last 4 quarters)
Bearish insider sentiment with recent selling by the General Counsel
AI Fair Value Estimate
Based on comprehensive analysis
$52.4
-22.6% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
52
Moderate
Value
30
Future
55
Past
60
Health
75
Dividend
40
AI Verdict
Overvalued Stable-Growth
Key drivers: Valuation premium, High payout ratio, Low debt, Bearish technicals
Confidence
90%
Value
30/100

Ref P/E 22.42, PEG 1.67, Graham $27.35

Positives
  • Forward P/E (17.88) is lower than current P/E
Watchpoints
  • Price is 147% above Graham Number
  • Price is 34% above Intrinsic Value
  • High Price/Book (6.15)
Future
55/100

Ref Growth rates

Positives
  • Steady YoY revenue growth (8.3%)
  • Positive earnings growth (6.5%)
Watchpoints
  • Low Q/Q revenue growth (2.96%)
  • Recent EPS growth is negative (-2.5% Q/Q)
Past
60/100

Ref Historical trends

Positives
  • Positive 3Y and 5Y returns
  • Long history of earnings reporting
Watchpoints
  • Recent trend of missing earnings estimates
Health
75/100

Ref Piotroski F-Score 5/9

Positives
  • Very low Debt/Equity (0.22)
  • Stable Piotroski F-Score (5/9)
Watchpoints
  • Lack of Altman Z-Score data for bankruptcy risk confirmation
Dividend
40/100

Ref Yield 3.96%, Payout 83.77%

Positives
  • Attractive yield of 3.96%
Watchpoints
  • Excessive payout ratio (83.77%)

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$67.71
Analyst Target
$66.33
Upside/Downside
-2.0%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for CNS and closest competitors.

Updated 2026-04-24
CNS
Cohen & Steers, Inc.
Primary
5Y
+17.7%
3Y
+24.6%
1Y
-8.7%
6M
-3.2%
1M
+9.4%
1W
+1.6%
PLM
Palomar Holdings, Inc.
Peer
5Y
+83.5%
3Y
+144.7%
1Y
-12.7%
6M
+16.7%
1M
+10.4%
1W
-1.7%
AHL
Aspen Insurance Holdings Limite
Peer
5Y
+14.7%
3Y
+14.7%
1Y
+14.7%
6M
+16.8%
1M
+0.6%
1W
-0.1%
BKU
BankUnited, Inc.
Peer
5Y
+51.1%
3Y
+53.0%
1Y
+23.4%
6M
+25.7%
1M
+6.1%
1W
+1.2%
INT
Inter & Co, Inc.
Peer
5Y
+143.9%
3Y
+342.0%
1Y
+64.3%
6M
-1.4%
1M
-4.3%
1W
+4.8%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
22.42
Forward P/E
17.88
PEG Ratio
1.67
P/B Ratio
6.15
P/S Ratio
6.13
EV/Revenue
5.96
EV/EBITDA
17.53
Market Cap
$3.48B

Profitability

Profit margins and return metrics

Profit Margin 27.46%
Operating Margin 34.41%
Gross Margin 46.83%
ROE N/A
ROA N/A

Growth

Revenue and earnings growth rates

Revenue Growth +8.3%
Earnings Growth +6.5%
Q/Q Revenue Growth +2.96%
Q/Q Earnings Growth +6.5%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.22
Low debt
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$6.05

Quarterly Earnings History

EPS performance vs analyst estimates

2026-07-16
$N/A
2026-04-16
$0.79
-3.7% surprise
2026-01-22
$0.81
2025-10-16
$0.81
+3.9% surprise

Financial Services Sector Comparison

Comparing CNS against 653 companies in the Financial Services sector (117 bullish, 269 neutral, 267 bearish)
P/E Ratio
22.42
This Stock
vs
38.75
Sector Avg
-42.1% (Discount)
Profit Margin
27.46%
This Stock
vs
58.65%
Sector Avg
-53.2% (Weaker)
Debt to Equity
0.22
This Stock
vs
1.52
Sector Avg
-85.6% (Less Debt)
Revenue Growth
8.3%
This Stock
vs
42.21%
Sector Avg
-80.3% (Slower)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

VILLANI EDMOND DENNIS
Director
Gift
2026-04-02
433 shares
THISSEN KAREN WILSON
Director
Stock Award
2026-04-01
440 shares
SMITH DASHA
Director
Stock Award
2026-04-01
440 shares
DOLLY LISA
Director
Stock Award
2026-04-01
440 shares
AGGARWAL REENA
Director
Stock Award
2026-04-01
440 shares
CONNOR FRANK T
Director
Stock Award
2026-04-01
440 shares
COHEN MARTIN
Director and Beneficial Owner of more than 10% of a Class of Security
Stock Award
2026-04-01
440 shares
VILLANI EDMOND DENNIS
Director
Stock Award
2026-04-01
440 shares
DONOHUE MICHAEL T
Chief Financial Officer
Stock Award
2026-03-19
213 shares
CHEIGH JON Y.
President
Stock Award
2026-03-19
924 shares
BROWN BRANDON
Officer
Stock Award
2026-03-19
134 shares
NOONAN DANIEL
Officer
Stock Award
2026-03-19
354 shares
DULIK ELENA
Officer
Stock Award
2026-03-19
52 shares
HARVEY JOSEPH M
Chief Executive Officer
Stock Award
2026-03-19
1,726 shares
DERECHIN ADAM M
Chief Operating Officer
Stock Award
2026-03-19
259 shares
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

8-K
8-K
2026-04-16

CNS likely filed this 8-K to report its first-quarter financial results for 2026.

DEF 14A
DEF 14A
2026-03-20

CNS filed a Definitive Proxy Statement on March 20, 2026, providing shareholders with necessary information to vote on corporate matters at the upcoming annual meeting.

10-K
10-K
2026-02-27

CNS submitted its annual 10-K filing on February 27, 2026, which includes standard disclosures regarding its business operations, risk factors, and financial condition. While specific financial metrics and risk details were not provided in the excerpts, the filing contains the required Management’s Discussion and Analysis and audited financial statements.

8-K
8-K
2026-01-22

CNS filed an 8-K on January 22, 2026, likely to announce its financial results for the preceding period.

10-Q
10-Q
2025-10-31

CNS submitted its 10-Q filing on October 31, 2025. While the document includes a section on Risk Factors under Item 1A, no specific financial highlights or detailed risk descriptions were provided in the available excerpts.

8-K
8-K
2025-10-16

CNS filed an 8-K on October 16, 2025, likely to report its third-quarter financial results.

8-K
8-K
2025-09-15
8-K
8-K
2025-08-15

CNS filed a current report on August 15, 2025, likely announcing its second-quarter financial results.

10-Q
10-Q
2025-08-01

CNS submitted its quarterly 10-Q filing on August 1, 2025. While specific financial metrics were not provided in the excerpt, the filing includes a dedicated section for risk factors under Item 1A.

8-K
8-K
2025-07-17
8-K
8-K
2025-05-05
10-Q
10-Q
2025-05-02
8-K
8-K
2025-04-16
DEF 14A
DEF 14A
2025-03-21
8-K
8-K
2025-03-10
Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
HOLD
3 analysts
Evercore ISI Group
2026-04-10
Maintains
Outperform Outperform

Past News Coverage

Recent headlines mentioning CNS from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile